Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Catheter Precision's share price for the quarter that ended in Sep. 2024 was $0.3951. Catheter Precision's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 3.45 Mil. Therefore, Catheter Precision's market cap for the quarter that ended in Sep. 2024 was $1.36 Mil.
Catheter Precision's quarterly market cap
increased
from Mar. 2024 ($3.68 Mil) to Jun. 2024 ($4.43 Mil) but then
declined
from Jun. 2024 ($4.43 Mil) to Sep. 2024 ($1.36 Mil).
Catheter Precision's annual market cap
increased
from Dec. 2021 ($10.92 Mil) to Dec. 2022 ($12.72 Mil) but then
declined
from Dec. 2022 ($12.72 Mil) to Dec. 2023 ($2.84 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Catheter Precision's Enterprise Value for Today is $3.71 Mil.
Catheter Precision Market Cap Historical Data
The historical data trend for Catheter Precision's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catheter Precision's Market Cap
For the Medical Devices subindustry, Catheter Precision's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Market Cap distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Market Cap falls into.
Catheter Precision Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Catheter Precision's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (AMEX:VTAK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Catheter Precision Market Cap Related Terms
Thank you for viewing the detailed overview of Catheter Precision's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTAK has been successfully added to your 